These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37559469)

  • 1. Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
    Xu J; Ren G; Cheng Q
    Technol Cancer Res Treat; 2023; 22():15330338231190737. PubMed ID: 37559469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming.
    Cao J; Sun X; Zhang X; Chen D
    Am J Med Sci; 2020 Sep; 360(3):279-286. PubMed ID: 32829780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming.
    Ma L; Cheng Q
    Biochem Biophys Res Commun; 2018 Apr; 498(4):912-917. PubMed ID: 29534964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance.
    Sarfraz I; Rasul A; Hussain G; Shah MA; Zahoor AF; Asrar M; Selamoglu Z; Ji XY; Adem Ş; Sarker SD
    Biofactors; 2020 Jul; 46(4):550-562. PubMed ID: 32039535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
    Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
    Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.
    Chittaranjan S; Bortnik S; Dragowska WH; Xu J; Abeysundara N; Leung A; Go NE; DeVorkin L; Weppler SA; Gelmon K; Yapp DT; Bally MB; Gorski SM
    Clin Cancer Res; 2014 Jun; 20(12):3159-73. PubMed ID: 24721646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
    Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
    Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.
    Chan B; VanderLaan PA; Sukhatme VP
    Biochem Biophys Res Commun; 2013 Sep; 439(2):247-51. PubMed ID: 23973484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
    Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
    Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.
    Yang X; Peng X; Huang J
    Clin Transl Oncol; 2018 Sep; 20(9):1145-1152. PubMed ID: 29340974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
    Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
    Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model.
    Zhang Q; Zhang Y; Wang C; Tang H; Ma A; Gao P; Shi Q; Wang G; Shen S; Zhang J; Xia F; Zhu Y; Wang J
    Phytomedicine; 2024 Jul; 129():155657. PubMed ID: 38692076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
    Guo H; Xiang Z; Zhang Y; Sun D
    Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence.
    Sukhatme VP; Chan B
    FEBS Lett; 2012 Jul; 586(16):2389-95. PubMed ID: 22677172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structures of 6-Phosphogluconate Dehydrogenase from
    Yu H; Hong J; Seok J; Seu YB; Kim IK; Kim KJ
    J Microbiol Biotechnol; 2023 Oct; 33(10):1361-1369. PubMed ID: 37417004
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
    Shan C; Elf S; Ji Q; Kang HB; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
    Mol Cell; 2014 Aug; 55(4):552-65. PubMed ID: 25042803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer.
    Zheng W; Feng Q; Liu J; Guo Y; Gao L; Li R; Xu M; Yan G; Yin Z; Zhang S; Liu S; Shan C
    Front Pharmacol; 2017; 8():421. PubMed ID: 28713273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions.
    Yao P; Sun H; Xu C; Chen T; Zou B; Jiang P; Du W
    J Biol Chem; 2017 Oct; 292(41):17113-17120. PubMed ID: 28848047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of 6-phosphogluconate dehydrogenase generates CD8
    Daneshmandi S; Cassel T; Lin P; Higashi RM; Wulf GM; Boussiotis VA; Fan TW; Seth P
    Cell Rep; 2021 Mar; 34(10):108831. PubMed ID: 33691103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism.
    Polat IH; Tarrado-Castellarnau M; Bharat R; Perarnau J; Benito A; Cortés R; Sabatier P; Cascante M
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.